SynthesisBMC endocrine disorders2021

The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis.

Yunzhi Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.